medigraphic.com
ISSN 0188-9796 (Print)

2012, Number 3

<< Back

Rev Endocrinol Nutr 2012; 20 (3)

Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents

Fraire GDC

Language: Spanish
References: 5
Page: 131-133
PDF size: 118.33 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Vign eri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009; 16: 1103-1123.

  2. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord. 2009; 7: 375-380.

  3. Currie CJ, Poole CD, Gale EA. The influence of glucose lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009; 52: 1766-1777.

  4. Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, GansRO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010; 33: 322-326.

  5. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 2006; 29: 254-258.




2020     |     www.medigraphic.com